What is ICU Medical's SG&A?

ICU Medical (ICUI) reported SG&A of $154.57M in Q1 2026.

How has ICU Medical's SG&A changed year-over-year?

ICU Medical's SG&A decreased by 1.7% year-over-year, from $157.23M to $154.57M.

What is the long-term trend for ICU Medical's SG&A?

Over 4 years (2021 to 2025), ICU Medical's SG&A has grown at a 19.9% compound annual growth rate (CAGR), from $302.58M to $625.21M.

Combined selling expenses (sales force, marketing, distribution) and general & administrative costs (management, legal, accounting, facilities) — the broadest opex category.

ICU Medical ICUI SG&A

SG&A at other companies

Option Care Health, Inc.OPCH

$174.56M+3.8%

Merit Medical SystemsMMSI

$118.21M+10.0%

Baxter InternationalBAX

$728M+3.6%

Becton, Dickinson and CompanyBDX

$1.21B+8.6%

TFX

TeleflexTFX

$226.01M+47.8%

MoogMOG.A

——

Other financials

Income statement

See full

Revenue$530.2M-12.3%

Gross profit$206.2M-1.8%

Operating income$13.6M+5.4%

Net income$30.1M+295%

EPS (diluted)$1.20+290%

Balance sheet

See full

Cash & equivalents$288.3M-0.5%

Total debt$1.4B-17.5%

Total equity$2.1B+6.3%

Total assets$4.0B-4.1%

Cash flow

See full

Operating cash flow$38.9M-24.2%

CapEx$11.3M-22.7%

Free cash flow$27.6M-24.8%

Valuation

See full

Market cap$3.51B-6.3%

Enterprise value$4.58B-10.6%

P/E75.3×+70.9×

P/S1.6×+0.1×

Profitability

See full

Gross margin37.9%+2.8pp

Operating margin2%-0.7pp

Net margin-0.3%-0.2pp

FCF margin4.2%-1.2pp

Returns & leverage

See full

Return on equity-0.4%-0.2pp

Debt / equity0.6×-0.2×

Current ratio2.3×-0.3×

Where this comes from

Reported directly by ICU Medical in its filing.

Tagged under the XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense.

The official record: ICU Medical’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about ICU Medical's sg&a.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is ICU Medical's SG&A?: ICU Medical (ICUI) reported SG&A of $154.57M in Q1 2026.
How has ICU Medical's SG&A changed year-over-year?: ICU Medical's SG&A decreased by 1.7% year-over-year, from $157.23M to $154.57M.
What is the long-term trend for ICU Medical's SG&A?: Over 4 years (2021 to 2025), ICU Medical's SG&A has grown at a 19.9% compound annual growth rate (CAGR), from $302.58M to $625.21M.
What does SG&A mean?: Combined selling expenses (sales force, marketing, distribution) and general & administrative costs (management, legal, accounting, facilities) — the broadest opex category.